CD274 and breast carcinoma: TNBC could also increase PD-L1 expression, fostering an immunosuppressive TME via the activation of the Wnt signaling pathway, a miscellaneous pathway that participates in the proliferation, metastasis, and therapeutic resistance of breast cancer [31,32,33].